Both in Pharmaceuticals
MetaVia vs GT Biopharma
Over the past year MTVA returned −87.2% and GTBP returned −68.1%; their daily moves had a correlation of 0.01.
MTVA −87.2% GTBP −68.1%Growth of $1, one year, split-adjusted
| Metric | MTVA | GTBP |
|---|---|---|
| Price | $1.38 | $5.46 |
| Market cap | $9.1M | $9.9M |
| Today | −0.72% | −1.09% |
| 1 month | −15.3% | −20.1% |
| 6 months | −11.5% | −30.1% |
| Year to date | −83.6% | −72.2% |
| 1 year | −86.9% | −67.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.8M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 54.5% | 958.1% |
| Short % of float | 3.5% | 22.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).